Mechanisms of Hippo signaling in Alcoholic liver disease

Hippo 信号在酒精性肝病中的机制

基本信息

  • 批准号:
    9296288
  • 负责人:
  • 金额:
    $ 24.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-20 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

Alcoholic liver disease (ALD), a major cause of morbidity and mortality worldwide, includes a broad spectrum of disorders, ranging from simple steatosis to severe forms of liver injury such as steatohepatitis, alcoholic hepatitis, cirrhosis, liver failure and hepatocellular carcinoma. Aside from the direct cytotoxic and the oxidative- stress–mediated effects that alcohol and its metabolites exert on hepatocytes, alcohol ingestion also activates both the innate and adaptive immune responses in the liver, and dysregulates several important signaling pathways in the liver, thereby contributing to the pathogenesis of ALD. Recent studies suggest that impaired liver regeneration and inflammation are two important mechanisms contributing to liver failure in patients with alcoholic hepatitis. However, the underlying mechanisms remain unclear. The Hippo (Hpo) signaling pathway has recently emerged as a critical one regulating hepatocyte proliferation, survival as well as inflammation. Central to the Hpo pathway is the control of Yap/Taz transcription factors by a kinase cascade starting from the Hpo kinase, which are Mst1 and Mst2 in mammals. As hepatocyte injury is a major driving force for ALD pathogenesis, the goal of this explorative R21 proposal is to determine whether alcohol attenuates liver regeneration and induces liver inflammation by dysregulating the Hpo signaling pathway in hepatocytes. Despite the critical functions of Hpo signaling in restricting hepatocyte proliferation and survival we and others have identified, the precise functions and molecular mechanisms whereby the Hpo signaling pathway participates in alcohol-induced liver injury, inflammation and regeneration are mostly unknown. Hence, there are many unanswered fundamental questions regarding Hpo signaling in ALD. The knowledge gained from the proposed studies will establish a solid new foundation for further mechanistic investigation of Hpo signaling in ALD and provide new targets and strategies to protect liver from alcohol induced injury. Our unpublished preliminary data show that in a short-term chronic-binge ALD (E1d-1B) model, Mst1, Mst2 and Yap protein levels were reduced. We have also found that, infiltrated macrophage numbers and expression of pro- inflammatory cytokines are increased in the hepatocyte-specific Mst1 and Mst2 double mutant (DKO) liver. We hypothesize that reduction in Yap expression leads to increased hepatocyte cell death and impaired hepatocyte regeneration; while Mst1 and Mst2 down-regulation in hepatocytes of the alcoholic liver contributes to chronic pro-injury liver inflammation. In Specific Aim 1, we will define the effects of alcohol consumption on the Hpo signaling pathway in hepatocytes. In Specific Aim 2, we will determine whether alcohol feeding inhibits liver regeneration by reducing Yap in hepatocytes. In Specific Aim 3, we will determine whether alcohol feeding causes liver inflammation by reducing Mst1 and Mst2 in hepatocytes.
酒精性肝病(ALD)是世界范围内发病率和死亡率的主要原因之一,其发病范围很广

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yingzi Yang其他文献

Yingzi Yang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yingzi Yang', 18)}}的其他基金

Cellular and molecular mechanism of Hippo signaling in suppressing liver tumor formation
Hippo信号抑制肝脏肿瘤形成的细胞和分子机制
  • 批准号:
    10216195
  • 财政年份:
    2018
  • 资助金额:
    $ 24.37万
  • 项目类别:
Cellular and molecular mechanism of Hippo signaling in suppressing liver tumor formation
Hippo信号抑制肝脏肿瘤形成的细胞和分子机制
  • 批准号:
    10449975
  • 财政年份:
    2018
  • 资助金额:
    $ 24.37万
  • 项目类别:
Cellular and molecular mechanism of Hippo signaling in suppressing liver tumor formation
Hippo信号抑制肝脏肿瘤形成的细胞和分子机制
  • 批准号:
    9978754
  • 财政年份:
    2018
  • 资助金额:
    $ 24.37万
  • 项目类别:
Molecular Mechanism of Wnt/Planar Cell Polarity Signaling
Wnt/平面细胞极性信号传导的分子机制
  • 批准号:
    9219069
  • 财政年份:
    2017
  • 资助金额:
    $ 24.37万
  • 项目类别:
Mechanisms of Hippo signaling in Alcoholic liver disease
Hippo 信号在酒精性肝病中的机制
  • 批准号:
    9532021
  • 财政年份:
    2017
  • 资助金额:
    $ 24.37万
  • 项目类别:
Molecular Mechanism of Wnt/Planar Cell Polarity Signaling
Wnt/平面细胞极性信号传导的分子机制
  • 批准号:
    10288018
  • 财政年份:
    2017
  • 资助金额:
    $ 24.37万
  • 项目类别:
Gas-Hedgehog signaling in intramembranous bone formation and expansion
Gas-Hedgehog 信号在膜内骨形成和扩张中的作用
  • 批准号:
    9977003
  • 财政年份:
    2016
  • 资助金额:
    $ 24.37万
  • 项目类别:
Gas-Hedgehog signaling in intramembranous bone formation and expansion
Gas-Hedgehog 信号在膜内骨形成和扩张中的作用
  • 批准号:
    9191649
  • 财政年份:
    2016
  • 资助金额:
    $ 24.37万
  • 项目类别:
Cxcl12-Hedgehog signaling in cranial bone regeneration
颅骨再生中的 Cxcl12-Hedgehog 信号传导
  • 批准号:
    10657799
  • 财政年份:
    2016
  • 资助金额:
    $ 24.37万
  • 项目类别:
Gas-Hedgehog signaling in intramembranous bone formation and expansion
Gas-Hedgehog 信号在膜内骨形成和扩张中的作用
  • 批准号:
    9310346
  • 财政年份:
    2016
  • 资助金额:
    $ 24.37万
  • 项目类别:

相似海外基金

Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 24.37万
  • 项目类别:
Evaluation of oral administration of PRIM-DJ2727 capsule containing microbiota suspension in patients with severe alcoholic hepatitis: An Open-Label Study
严重酒精性肝炎患者口服含有微生物悬浮液的 PRIM-DJ2727 胶囊的评价:一项开放标签研究
  • 批准号:
    10527603
  • 财政年份:
    2022
  • 资助金额:
    $ 24.37万
  • 项目类别:
Evaluation of oral administration of PRIM-DJ2727 capsule containing microbiota suspension in patients with severe alcoholic hepatitis: An Open-Label Study
严重酒精性肝炎患者口服含有微生物悬浮液的 PRIM-DJ2727 胶囊的评价:一项开放标签研究
  • 批准号:
    10686094
  • 财政年份:
    2022
  • 资助金额:
    $ 24.37万
  • 项目类别:
A novel therapy for acute alcoholic hepatitis
急性酒精性肝炎的新疗法
  • 批准号:
    10604068
  • 财政年份:
    2022
  • 资助金额:
    $ 24.37万
  • 项目类别:
An innovative non-thiazolidinedione pan-PPAR agonist therapeutic for Alcoholic Hepatitis
一种创新的非噻唑烷二酮类泛 PPAR 激动剂,用于治疗酒精性肝炎
  • 批准号:
    10482468
  • 财政年份:
    2022
  • 资助金额:
    $ 24.37万
  • 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
  • 批准号:
    10298412
  • 财政年份:
    2021
  • 资助金额:
    $ 24.37万
  • 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
  • 批准号:
    10494268
  • 财政年份:
    2021
  • 资助金额:
    $ 24.37万
  • 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
  • 批准号:
    10617893
  • 财政年份:
    2021
  • 资助金额:
    $ 24.37万
  • 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
  • 批准号:
    10646369
  • 财政年份:
    2021
  • 资助金额:
    $ 24.37万
  • 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
  • 批准号:
    10874892
  • 财政年份:
    2021
  • 资助金额:
    $ 24.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了